Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl) amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate

EU orphan designation number: EU/3/16/1612   
Active ingredient: Methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl) amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate
Indication: Treatment of pantothenate-kinase-associated neurodegeneration
Sponsor: Retrophin Europe Limited
2nd Floor, Palmerston House, Fenian Street, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/189/15 (2016)1105 of 17/02/2016
18/03/2016 Corrigendum (2016)1718 of 15/03/2016